Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;179(5):918-937.
doi: 10.1111/bph.15650. Epub 2021 Sep 4.

Rodent models of hypertension

Hamdi A Jama  1   2 , Rikeish R Muralitharan  1   3 , Chudan Xu  1 , Joanne A O'Donnell  1 , Mariane Bertagnolli  4   5 , Bradley R S Broughton  6 , Geoffrey A Head  6   7 , Francine Z Marques  1   2
Affiliations
Free article
Review

Rodent models of hypertension

Hamdi A Jama et al. Br J Pharmacol. 2022 Mar.
Free article

Abstract

Elevated blood pressure (BP), or hypertension, is the main risk factor for cardiovascular disease. As a multifactorial and systemic disease that involves multiple organs and systems, hypertension remains a challenging disease to study. Models of hypertension are invaluable to support the discovery of the specific genetic, cellular and molecular mechanisms underlying essential hypertension, as well as to test new possible treatments to lower BP. Rodent models have proven to be an invaluable tool for advancing the field. In this review, we discuss the strengths and weaknesses of rodent models of hypertension through a systems approach. We highlight the ways how target organs and systems including the kidneys, vasculature, the sympathetic nervous system (SNS), immune system and the gut microbiota influence BP in each rodent model. We also discuss often overlooked hypertensive conditions such as pulmonary hypertension and hypertensive-pregnancy disorders, providing an important resource for researchers. LINKED ARTICLES: This article is part of a themed issue on Preclinical Models for Cardiovascular disease research (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.5/issuetoc.

Keywords: Ang II; DOCA; SHR; inflammation; microbiome; salt.

PubMed Disclaimer

References

REFERENCES

    1. Abbate, M., Zoja, C., & Remuzzi, G. (2006). How does proteinuria cause progressive renal damage? Journal of the American Society of Nephrology, 17(11), 2974-2984. https://doi.org/10.1681/asn.2006040377
    1. Abe, K., Toba, M., Alzoubi, A., Ito, M., Fagan, K. A., Cool, C. D., Voelkel, N. F., McMurtry, I. F., & Oka, M. (2010). Formation of plexiform lesions in experimental severe pulmonary arterial hypertension. Circulation, 121(25), 2747-2754. https://doi.org/10.1161/circulationaha.109.927681
    1. Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., CGTP Collaborators, Abbracchio, M. P., Alexander, W., al-hosaini, K., Bäck, M., … Yao, C. (2019). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors. British Journal of Pharmacology, 176, S21-S141. https://doi.org/10.1111/bph.14748
    1. Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., CGTP Collaborators, Beuve, A., Boison, D., Brouckaert, P., Burnett, J. C., Burns, K., … Watts, V. (2019). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes. British Journal of Pharmacology, 176, S297-S396. https://doi.org/10.1111/bph.14752
    1. Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., CGTP Collaborators, Bryant, C., Farndale, R. W., Hobbs, A., Jarvis, G. E., MacEwan, D., … Waldman, S. (2019). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors. British Journal of Pharmacology, 176, S247-S296. https://doi.org/10.1111/bph.14751

Publication types